In vitro inhibitory effect of mesenchymal stem cells on zymosan-induced production of reactive oxygen species

Bulletin of Experimental Biology and Medicine

Volumn 146, Issue 1, 2008, Pages 158-164

  Tsyb, A F ^a   Petrov, V N ^a   Konoplyannikov, A G ^a   Saypina, E V ^a   Lepechina, L A ^a   Kalsina, S Sh ^a   Semenkova, I V ^a   Agaeva, E V ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Local immunosuppressive environment; Macrophages; Mesenchymal stem cells; Reactive oxygen radicals

Indexed keywords

REACTIVE OXYGEN METABOLITE; ZYMOSAN;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL COUNT; CELLULAR STRESS RESPONSE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CULTURE MEDIUM; ENRICHMENT CULTURE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MACROPHAGE FUNCTION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; REGULATORY MECHANISM;

BONE MARROW CELLS; CELLS, CULTURED; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGES, PERITONEAL; MESENCHYMAL STEM CELLS; REACTIVE OXYGEN SPECIES; ZYMOSAN;

EID: 58049179022     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-008-0238-8     Document Type: Article

References (22)

1. A. Yu. Andreev, Yu. E. Kushnareva, A. A. Starkov, Biokhimiya, 70, No. 2, 246-264 (2005).
2. Yu. Arnkhol'd, Ibid., 69, No. 1, 8-15 (2004).
3. M. Bra, B. Quinan, S. A. Suzin, Ibid., 70, No. 2, 284-293 (2005).
4. Yu. A. Vladimirov and M. P. Sherstnev, Advances in Science and Technology, Byophysics VINITY, Moscow (1989), Vol. 24, 1-120.
5. G. I. Deichman, Carcinogenesis, Ed. D. G. Zeridze, Moscow (2004), pp. 448-473.
6. Lymphocytes, Methods, Ed. J. Klaus, Moscow (1990), pp. 36-38.
7. E. G. Slavina, Advances in Science and Technology, Oncology. VINITY, Moscow (1984), Vol. 13, pp. 98-141.
8. A. F. Tsyb, M. A. Kaplan, V. N. Petrov, et al., Ros. Biother. Zh., 4, No. 4, 44-49 (2005).
9. A. F. Tsyb, A. G. Konoplyannikov, A. I. Kolesnikova, and V. V. Pavlov, Vestn. Ross. Akad. Med. Nauk., 59, No. 9, 71-76 (2004).
10. S. Aggarwal and M.F. Pittenger, Blood, 105, 1815-1822 (2005).
11. A. Bartholomew, C. Sturgeon, M. Siatskas, et al., Exp. Hematol., 30, 42-48 (2002).
12. S. Beyth, Z. Borovsky, D. Mevorach, et al., Blood, 105, 2214-2219 (2005).
13. D. English and B. R. Andersen, J. Immunol. Methods, 5, 249 (1974).
14. S. J. Forbes, P. Vig, R. Poulsom, et al. Clinical Science, 103, 355-369 (2002).
15. Z. Guo, H. Li, X. Li, et al., Stem Cells, 24, 992-1000 (2006).
16. S. L. Helfand, J. Werkmeister, J. C. Roder, J. Exp. Med., 156, 492-505 (1982).
17. K. Le Blanc and O. Ringden, Biol. Blood and Marrow Transplant., 11, 321-334 (2005).
18. H. Liu, D. M. Kemeny, B. C. Heng, et al., J. Immunol., 176, 2864-2871 (2006).
19. K. McIntosh, S. Zvonic, S. Garrett, et al., Stem Cells, 24, 1246-1253 (2006).
20. P. A. Sotiropoulou, S. A. Perez, A. D. Gritzapis, et al., Stem Cells, 24, 74-85 (2006).
21. G. M. Spaggiari, A. Capobianco, S. Becchetti, et al., Blood, 107, 1484-1490 (2006).
22. J. M. Ryan, F. P. Barry, J. M. Murphy, and B. P. Mahon, J. Inflammation., 2, 18-30 (2005).